Comparison of Different In Vivo Incubation Sites to Produce Tissue-Engineered Small Intestine

被引:0
|
作者
Liu, Yanchun [1 ]
Cromeens, Barrett P. [1 ]
Wang, Yijie [1 ]
Fisher, Kelli [1 ]
Johnson, Jed [2 ]
Chakroff, Jason [2 ]
Besner, Gail E. [1 ]
机构
[1] Nationwide Childrens Hosp, Res Inst, Dept Pediat Surg, FB6135,700 Childrens Dr, Columbus, OH 43205 USA
[2] Nanofiber Solut Inc, Hilliard, OH USA
关键词
tissue-engineered intestine; tissue maturation; animal model; vascularized pedicle; intestinal mesentery; VISCERAL ADIPOSITY; ANASTOMOSIS; GROWTH; ANGIOGENESIS; NEOINTESTINE; SCAFFOLDS; HYDROGELS;
D O I
10.1089/ten.tea.2017.0313
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Objective: The objective of this study was to compare the impact of different in vivo incubation sites on the production of tissue-engineered small intestine (TESI). Materials and Methods: Green fluorescent protein transgenic rat pups (3-5 days) were used as donors of intestinal organoids. Harvested intestine was exposed to enzymatic digestion to release intestinal stem cell-containing organoids. Organoids were purified, concentrated, and seeded onto tubular polyglycolic acid scaffolds. Seeded scaffolds were implanted in each of five locations in recipient female nude rats: wrapped with omentum, wrapped with intestinal mesentery, wrapped with uterine horn membrane, attached to the abdominal wall, and inserted into the subcutaneous space. After 4 weeks of in vivo incubation, specimens from each site were explanted for evaluation. Results: Wrapping seeded scaffolds with vascularized membranes produced TESI with variable lengths of vascularized pedicles, with the longest pedicle length from uterine horn membrane, the shortest pedicle length from intestinal mesentery, and intermediate length from omentum. The quantity of TESI, as expressed by volume and neomucosal length, was identical in TESI produced by wrapping with any of the three membranes. The smallest quantity of TESI was found in TESI produced from insertion into the subcutaneous space, with an intermediate quantity of TESI produced from attachment to the abdominal wall. Periodic acid-Schiff and immunofluorescence (IF) staining confirmed the presence of all intestinal epithelial cell lineages in TESI produced at all incubation sites. Additional IF staining demonstrated the presence of enteric nervous system components and blood vessels. Wrapping of seeded scaffolds with vascularized membranes significantly increased the density of blood vessels in the TESI produced. Conclusion: Wrapping of seeded scaffolds in vascularized membranes produced the largest quantity and highest quality of TESI. Attaching seeded scaffolds to the abdominal wall produced an intermediate quantity of TESI, but the quality was still comparable to TESI produced in vascularized membranes. Insertion of seeded scaffolds into the subcutaneous space produced the smallest quantity and lowest quality of TESI. In summary, wrapping seeded scaffolds with vascularized membranes is favorable for the production of TESI, and wrapping with omentum may produce TESI that is most easily anastomosed with host intestine.
引用
收藏
页码:1138 / 1147
页数:10
相关论文
共 50 条
  • [41] In vitro fabrication of tissue-engineered bones and in vivo transplantation
    Song, K. D.
    Liu, T. Q.
    TISSUE ENGINEERING, 2007, 13 (07): : 1712 - 1712
  • [42] Tissue-engineered small intestine (TESI) forms normal architecture following a period of hyper-proliferation
    Levin, Daniel E.
    Sala, Frederic G.
    Barthel, Erik R.
    Speer, Allison L.
    Hou, Xiaogang
    Torashima, Yasuhiro
    Dreyfuss, Justin M. L.
    Grikscheit, Tracy C.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2012, 215 (03) : S137 - S137
  • [43] Cultured chondrocytes produce injectable tissue-engineered cartilage in hydrogel polymer
    Passaretti, D
    Silverman, RP
    Huang, W
    Kirchhoff, CH
    Ashiku, S
    Randolph, MA
    Yaremchuk, MJ
    TISSUE ENGINEERING, 2001, 7 (06): : 805 - 815
  • [44] Comparison of Different Ages of Cell Donors for the Production of Tissue Engineered Intestine (TEI)
    Liu, Y.
    Cromeens, B.
    Wang, Y.
    Johnson, J.
    Chakroff, J.
    Besner, G. E.
    TISSUE ENGINEERING PART A, 2016, 22 : S155 - S155
  • [45] Development of in vivo Tissue-Engineered Vascular Grafts With an Ultra Small Diameter of 0.6 mm (MicroBiotubes)
    Ishii, Daizo
    Enmi, Jun-Ichiro
    Lida, Hidehiro
    Satow, Tetsu
    Takahashi, Jun C.
    Kurisu, Kaoru
    Nakayama, Yasuhide
    CIRCULATION, 2015, 132
  • [46] Perfusion Bioreactor for small diameter tissue-engineered arteries
    Williams, C
    Wick, TM
    TISSUE ENGINEERING, 2004, 10 (5-6): : 930 - 941
  • [47] Biofabrication of small diameter tissue-engineered vascular grafts
    Weekes, Angus
    Bartnikowski, Nicole
    Pinto, Nigel
    Jenkins, Jason
    Meinert, Christoph
    Klein, Travis J.
    ACTA BIOMATERIALIA, 2022, 138 : 92 - 111
  • [48] Injectable tissue-engineered cartilage with different chondrocyte sources
    Xu, JW
    Zaporojan, V
    Peretti, GM
    Roses, RE
    Morse, KB
    Roy, AK
    Mesa, JM
    Randolph, MA
    Bonassar, LJ
    Yaremchuk, MJ
    PLASTIC AND RECONSTRUCTIVE SURGERY, 2004, 113 (05) : 1361 - 1371
  • [49] Chorioallantoic membrane for in vivo investigation of tissue-engineered construct biocompatibility
    Baiguera, Silvia
    Macchiarini, Paolo
    Ribatti, Domenico
    JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS, 2012, 100B (05) : 1425 - 1434
  • [50] An Overview of Methods for the In Vivo Evaluation of Tissue-Engineered Skin Constructs
    Lammers, Gerwen
    Verhaegen, Pauline D. H. M.
    Ulrich, Magda M. W.
    Schalkwijk, Joost
    Middelkoop, Esther
    Weiland, Daniela
    Nillesen, Suzan T. M.
    Van Kuppevelt, Toin H.
    Daamen, Willeke F.
    TISSUE ENGINEERING PART B-REVIEWS, 2011, 17 (01) : 33 - 55